ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,715.28
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,617.56
-0.42%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Alseres Pharmaceuticals Inc (CE) (ALSE)

  7. Alseres Pharmaceuticals Inc (CE) (ALSE) News

Alseres Pharmaceuticals (CE) (ALSE)

Alseres Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ALSE
DateTimeSourceHeadlineSymbolCompany
21/11/201421:10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
18/11/201420:09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
14/08/201412:09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
23/05/201417:04Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
16/05/201413:46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
10/04/201412:52Edgar (US Regulatory)Annual Report (10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
31/03/201421:00Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
31/03/201421:00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
31/07/201312:29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
17/05/201318:47Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
16/05/201318:44Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
01/04/201317:23Edgar (US Regulatory)Annual Report (10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
21/02/201320:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
07/02/201313:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201319:40Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201319:40Edgar (US Regulatory)Annual Report (management Company) (nsar-b)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201319:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201317:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
08/01/201315:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
08/01/201315:21Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
14/11/201211:08Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
14/11/201211:08Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
13/08/201210:16Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
23/07/201210:02Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
02/07/201212:30Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
13/06/201214:06Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
11/05/201219:18Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
08/05/201220:12Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
29/03/201220:50Edgar (US Regulatory)Annual Report (10-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
19/03/201219:50Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ALSE

Your Recent History

LSE
POS
Plexus
LSE
CPI
Capita
LSE
VAST
Vast Resources
LSE
TPL
Tethys
LSE
NESF
Nextenergy Solar
LSE
DEC
Diversified Energy
NASDAQ
SMCI
Super Micro Computer
LSE
TSLA
1x Tsla
LSE
SYME
Supply@me Capital
LSE
SRSP
Sirius Petroleum
LSE
GOLD
LSE
MIN
Minoan
LSE
OCDO
Ocado
LSE
SCLP
Scancell
LSE
LLOY
Lloyds Banking
LSE
GGP
Greatland Gold
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06